Drugs Targeting Epithelial–Mesenchymal Transition Molecules for Treatment of Lichen Planopilaris
May 2022
in “
Clinical and experimental dermatology
”
Studysummary This review discusses potential EMT-targeting drugs for treating lichen planopilaris and emphasizes the need for clinical trials, as current evidence is limited to individual cases or case series.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on academic.oup.com →